secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001628280-23-025955
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx CMO Babak Azad departs; separation deal includes $205K lump sum, equity vest
--------------------------------------------------------------------------------

- Azad's last day as CMO was July 7, 2023; separation agreement entered July 26, 2023.
- Lump sum payment of $205,000; immediate vesting of 50,000 option shares and 20,402 RSUs.
- Option exercise extended to 6 months post-separation; COBRA premium reimbursement for 9 months.
- Mutual non-disparagement and full release of claims; agreement effective Aug 2, 2023 if not revoked.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000162828023025955/0001628280-23-025955-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000162828023025955/gdrx-20230726.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-025955

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer